Effects of epigallocatechin-3-gallate of Camellia sinensis leaves on blood pressure, lipid profile, atherogenic index of plasma and some inflammatory and antioxidant markers in type 2 diabetes mellitus patients: a clinical trial

Author:

Bazyar Hadi1,Hosseini Seyed Ahmad2,Saradar Sirous3,Mombaini Delsa2,Allivand Mohammad2,Labibzadeh Maryam4,Alipour Meysam5ORCID

Affiliation:

1. Student Research Committee , Ahvaz Jundishapur University of Medical Sciences , Ahvaz , Iran

2. Nutrition and Metabolic Diseases Researcher Center , Ahvaz Jundishapur University of Medical Sciences , Ahvaz , Iran

3. Ahvaz Jundishapur University of Medical Sciences , Ahvaz , Iran

4. Institute for Higher Education ACECR , Khouzestan , Iran

5. Alimentary Tract Research Center , Ahvaz Jundishapur University of Medical Sciences , Ahvaz , Iran

Abstract

Abstract Background In patients with type 2 diabetes mellitus (T2DM) the inflammatory and metabolic responses to epigallocatechin-3-gallate (EGCG) are unknown. Objectives Evaluate the impacts of EGCG on metabolic factors and some biomarkers of stress oxidative in patients with T2DM. Methods In this randomized, double-blind, placebo-controlled trial, 50 patients with T2DM consumed either 2 tablets (300 mg) EGCG (n=25) or wheat flour as placebo (n=25) for 2 months. The total antioxidant capacity (TAC), interleukin-6 (IL-6), lipid profile, mean arterial pressure (MAP), atherogenic index of plasma (AIP) were evaluated before and after the intervention. Results The finding of present study exhibited a significant increase in the serum levels of TAC after the EGCG supplementation (p=0.001). Also, in compare with control group, the mean changes of TAC were significantly higher in supplement group (p=0.01). In intervention group, a significant decrease was observed in the mean levels of triglyceride, total cholesterol, diastolic blood pressure (DBP), AIP, and MAP (p<0.05). Taking EGCG resulted in the mean changes of total cholesterol, MAP and DBP were significantly lower in compare with control group (p<0.05). Conclusions This study recommended that EGCG supplementation may be improved blood pressure, lipid profile, AIP, and oxidative status in patients with T2DM.

Publisher

Walter de Gruyter GmbH

Subject

Complementary and alternative medicine

Reference32 articles.

1. Javid, AZ, Hosseini, SA, Gholinezhad, H, Moradi, L, Haghighi-zadeh, MH, Bazyar, H. Antioxidant and anti-inflammatory properties of melatonin in patients with type 2 diabetes mellitus with periodontal disease under non-surgical periodontal therapy: a double-blind, placebo-controlled trial. Diabetes, metabolic syndrome and obesity. Targets and Therapy 2020;13:753–61.

2. Ogurtsova, K, da Rocha Fernandes, J, Huang, Y, Linnenkamp, U, Guariguata, L, Cho, N, et al.. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024.

3. Bazyar, H, Adibmanesh, A, Javid, AZ, Maghsoumi-Norouzabad, L, Gravand, E, Alipour, M, et al.. The relationship between metabolic factors and anthropometric indices with periodontal status in type 2 diabetes mellitus patients with chronic periodontitis. Obes Med 2019;16:100138. https://doi.org/10.1016/j.obmed.2019.10013.

4. Tiwari, BK, Pandey, KB, Abidi, A, Rizvi, SI. Markers of oxidative stress during diabetes mellitus. J Biomark 2013;2013:378790. https://doi.org/10.1155/2013/378790.

5. Rehman, K, Akash, MSH. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked?. J Cell Biochem 2017;118:3577–85. https://doi.org/10.1002/jcb.26097.

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3